Sara Munjampalli, M.D.
Family Medicine Physician in Shreveport, Louisiana. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 147,640 in Family Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Sara Munjampalli, M.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 436 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 436
- Part D claims, 2023
- 82%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Sara Munjampalli, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Sara Munjampalli, M.D. sits
This provider among family medicine physician peers
Across the 22,040 family medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Sara Munjampalli, M.D. writes more Part D claims than 22% of them and scores higher on MIPS quality than 0% — placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one family medicine physician peer from a representative sample of 60; the gold marker is Sara Munjampalli, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Sara Munjampalli, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sara Munjampalli, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Louisiana
How Family Medicine Physician compares to other specialties among Louisiana providers
Largest specialties in Louisiana (% of in-state providers)
Family Medicine Physician ranks #15 among Louisiana's specialties (1.7% of in-state providers)
Each bar is a specialty's share of the Louisiana provider total, by primary NUCC taxonomy. The highlighted bar is Family Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance — MIPS
Sara Munjampalli, M.D.'s 2023 MIPS final score plotted against the Family Medicine Physician national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Family Medicine Physician) — 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Family Medicine Physician US NPIs
0/100 MIPS final score — 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Family Medicine Physician. Quality dim: 0.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Sara Munjampalli, M.D. appears in the CMS NPPES registry as a Family Medicine Physician provider holding M.D. credentials at 7600 FERN AVE STE 700A, Shreveport, LA, 71105, with a listed phone of (318) 657-0187. NPI 1437446341 was issued on 06/30/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Munjampalli most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 436 prescription claims written by this provider, covering 85 Medicare beneficiaries and totaling roughly $511K in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Family Medicine Physician is a high-volume specialty nationwide, with 147,640 enrolled providers across 56 states and an average of 3,418 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1437446341 |
|---|---|
| Specialty | Family Medicine Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/30/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Sara Munjampalli, M.D.'s current license status, disciplinary history, and board certifications with the Louisiana State Board of Medical Examiners in Louisiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where Sara Munjampalli, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sara Munjampalli, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$9.2K
Largest payer
JAZZ PHARMACEUTICALS INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
18% brand-name claims vs 82% generic, on 436 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 619
- Total Day Supply
- 18,360
- Brand vs Generic
- 18% brand / 82% generic
- Brand Drug Cost
- $504K
- Generic Drug Cost
- $6K
Patient Demographics
- Average Patient Age
- 63.7 years
- Avg HCC Risk Score
- 1.65
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 39, 65-74: 31, 75-84: 15, 85+: 0
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Sara Munjampalli, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Zolpidem Tartrate
Zolpidem Tartrate
102 claims
- Trazodone Hcl
Trazodone Hcl
69 claims
- Eszopiclone 30
Eszopiclone
30 claims
- Sunosi 24
Sunosi
24 claims
- Modafinil 18
Modafinil
18 claims
- Ropinirole Hcl 17
Ropinirole Hcl
17 claims
- Wakix 17
Wakix
17 claims
- Buspirone Hcl 13
Buspirone Hcl
13 claims
| Drug | Claims |
|---|---|
| Zolpidem Tartrate | 102 |
| Trazodone Hcl | 69 |
| Eszopiclone | 30 |
| Sunosi Solriamfetol Hcl | 24 |
| Modafinil | 18 |
| Ropinirole Hcl | 17 |
| Wakix Pitolisant Hcl | 17 |
| Buspirone Hcl | 13 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 12 |
| Vyvanse Lisdexamfetamine Dimesylate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Medicine Physician Overview
How Sara Munjampalli, M.D. fits within the Family Medicine Physician landscape nationally.
Sara Munjampalli, M.D.'s 436 claims are below the specialty average of 3,418.
Nearby Family Medicine Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Munjampalli.
Compare Family Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Louisiana medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Family Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Louisiana
Frequently Asked Questions
What is Sara Munjampalli, M.D.'s specialty? ▼
How much does Sara Munjampalli, M.D. prescribe under Medicare Part D? ▼
What is Sara Munjampalli, M.D.'s Medicare quality score? ▼
Where is Sara Munjampalli, M.D. located? ▼
What is Sara Munjampalli, M.D.'s NPI number? ▼
Does Sara Munjampalli, M.D. prescribe more brand-name or generic drugs? ▼
How many Family Medicine Physician providers are there in the US? ▼
What drugs does Sara Munjampalli, M.D. prescribe most often? ▼
Does Sara Munjampalli, M.D. accept Medicare? ▼
How can I verify Sara Munjampalli, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology